These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30335057)

  • 1. [Comparative morphological characteristics and immunophenotype of urothelial carcinomas of the renal pelvis and bladder].
    Osmanov YI; Gaibov ZA; Kogan EA; Radenska-Lopovok SG; Tursunov KZ
    Arkh Patol; 2018; 80(5):23-32. PubMed ID: 30335057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological and immunohistochemical characteristics of the molecular subtypes of urothelial carcinomas].
    Osmanov YI; Gaibov ZA; Kogan EA; Radenska-Lopovok SG; Tursunov KZ
    Arkh Patol; 2019; 81(5):35-44. PubMed ID: 31626203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.
    Perez-Montiel D; Wakely PE; Hes O; Michal M; Suster S
    Mod Pathol; 2006 Apr; 19(4):494-503. PubMed ID: 16474378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis.
    Gunia S; Erbersdobler A; Koch S; Otto W; Staibano S; D'Alterio C; Brookman-May S
    Hum Pathol; 2013 May; 44(5):712-7. PubMed ID: 23158209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
    Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
    Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary carcinoma of renal calyx.
    Williams PA; Mai KT
    Pathol Res Pract; 2013 Oct; 209(10):654-61. PubMed ID: 23999038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases.
    Gutierrez CM; Alemozaffar M; Osunkoya AO
    Hum Pathol; 2019 Oct; 92():18-24. PubMed ID: 31351154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data.
    Aragon-Ching JB; Nizam A; Henson DE
    Clin Genitourin Cancer; 2019 Dec; 17(6):436-442. PubMed ID: 31445851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
    Shiga M; Nagumo Y; Chihara I; Nitta S; Kojo K; Kimura T; Kandori S; Kojima T; Okuyama A; Higashi T; Nishiyama H
    Int J Urol; 2021 Aug; 28(8):814-819. PubMed ID: 34013614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional cell carcinoma of the renal pelvis with choriocarcinomatous differentiation. Immunohistochemical and immunoelectron microscopic assessment of human chorionic gonadotropin production by transitional cell carcinoma of the urinary bladder.
    Grammatico D; Grignon DJ; Eberwein P; Shepherd RR; Hearn SA; Walton JC
    Cancer; 1993 Mar; 71(5):1835-41. PubMed ID: 8448745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal pelvic urothelial carcinoma with divergent morphology.
    Xiao GQ; Unger PD
    Ann Diagn Pathol; 2010 Apr; 14(2):74-80. PubMed ID: 20227011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Markers of stem cells and their prognostic values for urothelial carcinomas of the urinary tract].
    Osmanov YI; Kogan EA; Rapoport LM; Teodorovich OV; Gaibov JA
    Urologiia; 2019 Jun; (2):40-49. PubMed ID: 31162900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
    Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
    Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
    J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synchronous manifestation of bladder inverted papilloma and transitional carcinoma of the renal pelvis].
    Pereira Arias JG; Zabalza Estévez I; Maraña Fernández M; Escobal Tamayo V; Catalina AJ; Paz Romeral JL; Ibarluzea González JG; Bernuy Malfaz C
    Arch Esp Urol; 1995 Dec; 48(10):1047-50. PubMed ID: 8588726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
    Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
    Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE
    Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.